63629-4014 Ondansetron

Product NDC:

63629-4014

Brand Name:

Ondansetron

Generic Name:

Ondansetron

Dosage Form Name:

TABLET, ORALLY DISINTEGRATING

Administration Route:

Oral

Substances:

Name: Ondansetron

Strength: 4.0

Unit: mg/1

Packages:

Code: 63629-4014-00

Description: 30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (63629-4014-0)

Effective Date: Nov. 1, 2012

Discontinued:

Code: 63629-4014-01

Description: 10 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (63629-4014-1)

Effective Date: May 29, 2009

Discontinued:

Code: 63629-4014-02

Description: 15 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (63629-4014-2)

Effective Date: Dec. 12, 2013

Discontinued:

Code: 63629-4014-03

Description: 20 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (63629-4014-3)

Effective Date: May 18, 2010

Discontinued:

Code: 63629-4014-04

Description: 5 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (63629-4014-4)

Effective Date: Nov. 10, 2010

Discontinued:

Code: 63629-4014-05

Description: 3 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (63629-4014-5)

Effective Date: Aug. 12, 2011

Discontinued:

Code: 63629-4014-06

Description: 14 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (63629-4014-6)

Effective Date: Dec. 22, 2021

Discontinued:

Code: 63629-4014-07

Description: 60 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (63629-4014-7)

Effective Date: March 20, 2013

Discontinued:

Code: 63629-4014-08

Description: 9 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (63629-4014-8)

Effective Date: Aug. 1, 2012

Discontinued:

Code: 63629-4014-09

Description: 6 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (63629-4014-9)

Effective Date: Aug. 9, 2012

Discontinued:

SEER*Rx Category:

Ancillary Therapy

Major Class:

Antiemetic

Minor Class:

5HT3 Receptor Antagonist

Orphan Drug Designation:

Status:

In Use

CanMED and the Oncology Toolbox

CanMED: NDC